A major genetic study has identified more regions of the genome linked to type 2 diabetes-related traits as a result of including multi-ethnic participants than if the research had been conducted only in Europeans, the researchers say. Previously, almost 90% of this type of genetic research had been conducted in Europeans. Read more
Pharma company Eli Lilly recently announced results of clinical trials for their new diabetes drug, Tirzepatide. The drug acts by mimicking the functions of incretin hormones, and would be a new type of medication to treat type 2 diabetes. It shows promise for improving blood glucose levels and helping achieve weight reduction. Read more
Long-term use of the common diabetes drug metformin use may have a protective effect on breast cancer risk for women with type 2 diabetes, researchers say. However, the effect of metformin depends on the breast cancer subtype. Read more
The FDA has cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical, an artificially intelligent insulin pen cap, for use in type 1 and type 2 diabetes patients aged 12 or older. The device has the potential to make insulin dosing much less burdensome for many patients. Read more
A new study examined what motivates type 2 diabetes patients’ preferences for either once-daily oral or once-weekly injectable medication. They found that initially, diabetes patients expressed a preference for the once-daily oral medication at approximately 3:1. However, many patients had a different opinion after learning more about the advantages and disadvantages of the once-weekly shot. […]
The COVID-19 pandemic has made managing their diabetes more difficult for many Americans, new research says. 19% of Americans with diabetes skipped at least one medical appointment due to fear of contracting the virus. Almost a quarter say that managing their diabetes has been difficult due to the pandemic, while 17% say they have developed […]
While insulin is the standard treatment for type 1 diabetes, it is also used for type 2 diabetes patients who are unable to reach their glycemic target with other medications. As the number of patients with type 2 prescribed insulin is growing, researchers sought to understand whether the risk for hypoglycemia associated with insulin could […]
Indexes of insulin sensitivity are a practical method for assessing type 2 diabetes risk without more complicated tests. However, while studies have compared the effectiveness of various indexes in predicting type 2 diabetes in whites, African Americans, Hispanic Americans, and other ethnicities, studies among the Asian population have been lacking. Read more
A new study conducted among 4,000 young men who had a stutter, between the ages of 16- and 20-years old, and living in Israel, found that teenagers who stutter may have a higher likelihood of developing early-onset type 2 diabetes. One explanation is that the anxiety a person may experience about their speech impediment could […]
Many patients with chronic kidney disease are at a higher risk for severe kidney and heart health issues. The DAPA-CKD trial was designed to see the impact of Dapagliflozin Propanediol, which is sold under the brand name Farxiga, in patients with and without type 2 diabetes who had chronic kidney disease. Read more
People who have type 2 diabetes often have reduced muscle strength, with the ability of the muscles to take up glucose impaired. Researchers have found that a particular gene that normally plays an important role in muscle regeneration is “silenced” in people who have type 2 diabetes. The discovery may lead to future new treatments. […]
A recent study says that the access of people with type 2 diabetes to sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment has significant ethnic, gender and socioeconomic disparities, with women, Black or Asian patients less likely to receive SGLT-2 inhibitor treatment. Read more
A new analysis of the Vitamin D and Type 2 Diabetes (D2d) study says that a daily supplementation of 100 μg (4,000 units) of vitamin D3, which would increase blood levels of vitamin D to higher levels than those considered adequate for bone health, may decrease the risk of type 2 diabetes in adults with […]
The widely used type 2 diabetes drug metformin is often associated with lactic acidosis, especially in patients with kidney disease. However, a new study suggests this may not the case for patients with mild to moderate kidney disease. Read more
SGLT-2 inhibitors, a diabetes drug class that includes drugs like canagliflozin (Invokana) have been shown to be beneficial for patients who have both type 2 diabetes and chronic kidney disease in regards to developing anemia. Read more
Tirzepatide, a newer diabetes drug, has been shown to reduce patient hemoglobin A1c levels, as well as lowering body weight and improving insulin sensitivity markers in patients with type 2 diabetes. Read more
The US Diabetes Prevention Program (DPP) multicenter trial established nearly 20 years ago that it is possible to delay or prevent prediabetes from progressing into full-blown type 2 diabetes. The DPP trial places greater emphasis on weight loss over physical activity, but is that emphasis in the right place? Diabetes exercise expert Dr. Sheri Colberg examines […]
Women who have obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, researchers say. PCOS is experienced by up to 10% of women of reproductive age, and between 50% and 80% of women with PCOS have obesity. Read more
Researchers say there is convincing evidence that people with type 2 diabetes have an increased risk of developing Parkinson’s disease. Type 2 diabetes is also linked to faster disease progression in patients who already have Parkinson’s. Read more
Researchers say the time of day at which men with type 2 diabetes and obesity or overweight performed moderate-to-vigorous physical activity made a difference in their cardiovascular fitness and health risks. They did not find the same effect in women who participated in the study. Read more
